《中国药典》2020年版一部导读  

A Guide to Understanding the Monographs of TCMs in 2020 Edition of Chinese Pharmacopoeia

作　　者：张鹏 申明睿 李浩 翟为民[1] 倪龙[1] 郝博[1] 石上梅[1] 杨昭鹏 兰奋[1] 张伟[1] ZHANG Peng;SHEN Mingrui;LI Hao;ZHAI Weimin;NI Long;HAO Bo;SHI Shangmei;YANG Zhaopeng;LAN Fen;ZHANG Wei(Chinese Pharmacopoeia Commission,Beijing 100061,China)

机构地区：[1]国家药典委员会,北京100061

出　　处：《中国药品标准》2020年第3期189-194,共6页Drug Standards of China

摘　　要：《中国药典》2020年版草案已经第十一届药典委员会执行委员会会议审议并通过。为了社会各界系统了解此版药典中药标准体系,本文从标准理念、主要增修订内容与编制思路三个方面介绍了以保障中药质量、满足临床需求而进行的相关标准工作,期望凝聚共识,促进新版药典标准的贯彻实施。The 2020 edition of Chinese Pharmacopoeia(Eleventh Edition of ChP)had been reviewed and adopted by the Plenary Session of the 11th Chinese Pharmacopoeia Commission Executive Committee.For a better understanding of the standard system of traditional Chinese medicines(TCMs)in this edition,this article introduces the relevant work which was intended to ensure the quality of TCMs and meet the clinical needs,from aspects of standard concept,main revisions and compilation ideas.And then tries to make more consensuses,to promote the implementation of the upcoming Pharmacopoeia.

关 键 词：标准体系 中药 质量 标准化 适用性 安全性 

分 类 号：R921.2[医药卫生—药学]